CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 17,778 shares at $21.37 ($384K) on 2016-12-14, disclosed to the SEC on 2016-12-16.
Open-market purchase of $384k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.37 | 670 | $14K | 3.7% |
| 2 | $21.37 | 1,439 | $31K | 8.0% |
| 3 | $21.37 | 1,000 | $21K | 5.6% |
| 4 | $21.37 | 2,810 | $60K | 15.7% |
| 5 | $21.37 | 270 | $6K | 1.5% |
| 6 | $21.37 | 2,810 |
| $60K |
| 15.7% |
| 7 | $21.37 | 270 | $6K | 1.5% |
| 8 | $21.37 | 670 | $14K | 3.7% |
| 9 | $21.37 | 1,000 | $21K | 5.6% |
| 10 | $21.37 | 1,439 | $31K | 8.0% |
| 11 | $22.05 | 110 | $2K | 0.6% |
| 12 | $22.05 | 321 | $7K | 1.8% |
| 13 | $22.05 | 400 | $9K | 2.3% |
| 14 | $22.05 | 579 | $13K | 3.3% |
| 15 | $22.05 | 1,290 | $28K | 7.4% |
| 16 | $22.05 | 400 | $9K | 2.3% |
| 17 | $22.05 | 110 | $2K | 0.6% |
| 18 | $22.05 | 1,290 | $28K | 7.4% |
| 19 | $22.05 | 321 | $7K | 1.8% |
| 20 | $22.05 | 579 | $13K | 3.3% |
| Total | $21.57 avg | 17,778 | $384K | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |